32 results about "Catalpic acid" patented technology

The invention relates to a mixture with aliphatic acid carbethoxy sulfonate salt, and relative production, wherein said mixture comprises 90-98 deals of aliphatic acid sulfonate salt, 1-4 deals of aliphatic acid sulfonate salt, 0.5-4 deals of sulfate, 0.1-2 deals of fatty acid ester, 0.3-3 deals of ethylsulfuric acid salt, and 1-50 deals of water. The production comprises that: 1, sulfonating the fatty acid ester and sulfur trioxide at 1:1-1:1. 1 mol ratios; 2, adding alcohol into mixture to be aged; 3, adding auricome into mixture to poach; 4, adding extractive into the mixture to extract; 5, adding alkali metal mixture into mixture to be neutralized to obtain the mixture. The inventive production is safe while the product purity is higher than 90%.

The invention relates to a harmless extraction process for preparing agricultural biochemical fulvic acid from livestock and poultry manure. The process includes an acid-soluble extraction process of fulvic acid and a Fenton oxidation degradation process. The process of acid-soluble extraction of fulvic acid is to combine the acid-soluble extractant of group A containing 0.1%~2.5% ferrous sulfate, pH value ≤ 2, and 1%~2.5% sulfuric acid with fermented livestock and poultry manure at a ratio of 1:5~15 The proportion of the solution is mixed into a suspension solution, stirred at room temperature for 30min~60min, the dissolved fulvic acid contains a chelate of organic acid and ferrous ion; the Fenton oxidation degradation process is to extract the material through acid dissolution, and Value ≤ 2, containing 15% hydrogen peroxide and B group acid soluble extractant containing 1% ~ 2.5% sulfuric acid mixed, the control material contains 0.5% ~ 3.0% hydrogen peroxide, after the two groups of materials are mixed, chlorine peroxide is Under the catalysis of ferrous ions, the Fenton oxidation degradation reaction is generated, and the residual antibiotics, hormones, pesticides, and pathogenic bacteria, decay-causing bacteria, and parasite eggs are rapidly degraded to achieve the effect of harmless extraction.

The invention discloses pseudoalteromonas sp.B3 and application thereof to biological oxidation of L-amino acid. During the application of the pseudoalteromonas sp.B3, an enzyme cultured by fermenting the pseudoalteromonas sp.B3 is taken as an enzyme source, the L-amino acid is taken as a substrate, and the enzyme source and the substrate react for 0.5-2h at a temperature of 25-50 DEG C and the pH value of 6-8 so as to oxidize the L-amino acid and release hydrogen peroxide. The invention provides a novel microbial strain for producing L-amino acid oxidase, and the strain can be use for biologically oxidizing the L-amino acid, has the characteristics of wide substrate spectrum, mild reaction, environment friendliness and the like, and has a wide application prospect in the aspects of quantitative analysis of the L-amino acid, splitting of the DL-amino acid and the like.

The invention discloses a preparation method of salicylamide derivatives shown in the formula 1. The preparation method comprises the following steps that 2,5-dimethoxyaniline is dissolved in an organic solvent and reacts with ethyl acetate of O-alkylacylsalicyloyl chlorine to produce N-(2-alkylacyloxyformoxy)-2,5-dimethoxyaniline; the N-(2-alkylacyloxyformoxy)-2,5-dimethoxyaniline reacts with R3OH in the presence of iodobenzene diacetate to produce 3-(O-alkylacylsalicyloylamino)-4,4-dialkoxy-2,5-cyclohexadienone; in an organic solvent (such as tetrahydrofuran, methanol and dimethyl formamide and especially such as dimethyl formamide), the 3-(O-alkylacylsalicyloylamino)-4,4-dialkoxy-2,5-cyclohexadienone undergoes a reaction in the presence of a hydrogen peroxide aqueous solution and an inorganic base to produce 5,6-epoxy-4,4-dialkoxy-3-salicyloylamido-2-cyclohexenone; the 5,6-epoxy-4,4-dialkoxy-3-salicyloylamido-2-cyclohexenone undergoes a reaction in the presence of a boron trifluoride ether complex to produce 5,6-epoxy-2-salicyloylamido-2-cyclohexenyl-1,4-dione; and the 5,6-epoxy-2-salicyloylamido-2-cyclohexenyl-1,4-dione is reduced into 5,6-epoxy-4-hydroxy-3-salicyloylamido-2-cyclohexenone (DHM2EQ) shown in the formula (1). The invention also relates to a preparation method of the 5,6-epoxy-4-hydroxy-3-salicyloylamido-2-cyclohexenone.

The invention relates to a method for preparing urea peroxide containing organic titanium by a recrystallization process. The method is characterized in that: new metatitanic acid precipitate of citric acid is prepared by neutralizing an iced solution of titanium salt by using alkali; the new metatitanic acid precipitate instead of titanium chloride and sulfate is used as raw materials for synthesizing citricacide-titatnium chelate; the citricacide-titatnium chelate is synthesized by a microwave hot melting chelation process by using the new metatitanic acid precipitate of citric acid as a titanium source and citric acid as an acid solvent and chelant; and the novel urea peroxide fertilizer containing the organic titanium is prepared by the steps of uniformly mixing hydrogen peroxide, acid citricacide-titatnium chelate and urea in a ratio, performing addition reaction on a mixture at the constant temperature of 60 DEG C, and recrystallizing at the temperature of less than or equal to 5 DEG C. The titanium element can strongly promote plant to absorb and convey nitrogen, phosphorus, potassium, other secondary elements and trace elements; the citricacide-titatnium chelate is reacted with hydrogen peroxide easily to form a titanium peroxide compound with high stability; and the citricacide-titatnium chelate can be used as stabilizer of urea peroxide, and synergist of urea peroxide nitrogenous fertilizer.

A method of treating and preventing type 2 diabetes and obesity an animal, including mammals and humans, in which a therapeutically effective amount of catalpic acid to the animal is administered orally or parentally.

A method of treating and preventing dyslipidemia, cardiovascular disease, type 2 diabetes, obesity and other diseases associated with the Metabolic Syndrome and of increasing the expression of genes that promote lipid oxidation in an animal, including mammals and humans, in which a therapeutically effective amount of catalpic acid is administered orally or parenterally to the animal.

The invention relates to a preparation method of a polyhydroxyl-modified soybean phosphatide fatliquoring agent. The soybean phosphatide fatliquoring agent is widely used for fatliquoring at present, while the traditional fatliquoring agent is relatively poor in water solubility and is also not good in filling property. The preparation method comprises the steps of placing 100 parts by mass of soybean phosphatide into a three-neck flask, then, adding 2-2.5 parts by mass of allyl glycidyl ether, heating to 40 DEG C, and reacting at the constant temperature for 2h; adding 5.4-7.7 parts by mass of formic acid into the system, dropwise adding 25-40 parts by mass of hydrogen peroxide within 1h by taking 0.5-1 part by mass of concentrated sulfuric acid as a catalyst, and reacting for 8-10h; heating the system to 75 DEG C, adding 40-65 parts by mass of sodium hydrogen sulfite, and reacting for 3h; and regulating the pH value of the system to 7.5-8 by using 40% NaOH, adding 60-DEG C hot water to regulate the solid content of the system to 60%, and stirring for 30min to obtain the improved fatliquoring agent. The soybean phosphatide fatliquoring agent prepared by using the method disclosed by the invention has better hydrophilicity.

Disclosed is a method for producing an alkanolamine salt of an a-sulfo fatty acid alkyl ester, comprising: a step of sulfonating a fatty acid alkyl ester to obtain a sulfonated compound; a step of reacting an alcohol and hydrogen peroxide with the sulfonated compound to obtain a reaction product; a step of adding an aqueous alkanolamine solution to the reaction product to obtain a neutralized product having a pH of 2 to 6.5; and a step of concentrating the neutralized product to obtain an aqueous paste containing an alkanolamine salt of an a-sulfo fatty acid alkyl ester. Accordingly, the deterioration of color tone at the time of concentration when preparing an aqueous paste of an alkanolamine salt of an a-sulfo fatty acid alkyl ester can be prevented.